
Humana rose 77.5% from $238.42 to $423.22, ahead of the S&P 500's +10.5%. Its worst day was Jan 27 (−21.1%), and its low came Mar 12 at $163.67.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Humana shares fell 21.1%, while the S&P 500 rose 0.4%.
−21.1%, the year's worst day, on 10M shares, the year's heaviest volume · S&P 500 +0.4%
EPS of $-3.96 beat the $-4.00 estimate on $32.6B revenue (est. $32.0B); FY EPS guidance of $9.00 against the $12.03 consensus.
Story events cover the past 12 months · Times ET
−3.3% · S&P 500 0.0%
Humana closed at its lowest level of the year, 31.4% below where the year started.
−4.3% · S&P 500 −1.5%
Humana shares rose 7.9%, while the S&P 500 rose 0.0%.
+7.9% · S&P 500 0.0%
EPS of $10.31 beat the $10.16 estimate on $39.6B revenue (est. $39.4B); FY revenue guidance of $160.0B against the $162.6B consensus.
+5.8% · S&P 500 0.0%
Humana shares rose 11.3%, while the S&P 500 rose 0.8%.
+11.3% · S&P 500 +0.8%
Humana (NYSE:HUM) FY2026 Preliminary Adj EPS expected to be more than $9.00 vs $8.72 Est
+7.5% · S&P 500 +0.3%
EPS of $7.61 beat the $6.81 estimate on $40.9B revenue (est. $40.6B); FY revenue guidance of $160.0B against the $162.4B consensus.
−6.0% · S&P 500 −1.5%
Humana (NYSE:HUM) FY2026 expected to be more than $9.00 vs $9.15 Est..
+11.6%, the year's best day · S&P 500 +0.6%
EPS of $-0.70 beat the $-1.01 estimate on $41.2M revenue (est. $40.8B); FY revenue guidance of $160.0B against the $162.5B consensus.
+5.3% · S&P 500 +0.3%
Where it ended: a close of $423.22 on Nov 9, 2026. Up next: Q4 2026 earnings on Feb 10, 2027 (EPS est. $-7.92, revenue est. $41.2B).
As of the Nov 9, 2026 close
Replay the year: the line draws itself and stops at each of the 10 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for HUM and SPY from Benzinga historical bars. Not investment advice.